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Summary
The glycolytic enzyme glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) has been traditionally consid-
ered a housekeeping protein involved in energy genera-
tion. However, evidence indicates that GAPDHs from
different origins are tightly regulated and that this regu-
lation may be on the basis of glycolysis-related and gly-
colysis-unrelated functions. In Saccharomyces
cerevisiae, Tdh3 is the main GAPDH, although two
other isoenzymes encoded by TDH1 and TDH2 have
been identified. Like other GAPDHs, Tdh3 exists pre-
dominantly as a tetramer, although dimeric and mono-
meric forms have also been isolated. Mechanisms of
Tdh3 regulation may thus imply changes in its oligo-
meric state or be based in its ability to interact with
Tdh1 and/or Tdh2 to form hybrid complexes. However,
no direct evidence of the existence of these interactions
has been provided and the exact function of Tdh1,2 is
unknown. Here, we show that Tdh1,2 immunopurified
with a GFP-tagged version of Tdh3 and that lack of this
interaction stimulates the Tdh3’s aggregation.
Furthermore, we found that the combined knockout of
TDH1 and TDH2 promotes the loss of cell’s viability and
increases the growing rate, glucose consumption and
CO2 production, suggesting a higher glycolytic flux in
the mutant cells. Consistent with this, the tdh3 strain,
which displays impaired in vitro GAPDH activity, exhib-
ited the opposite phenotypes. Quite remarkably, tdh1
tdh2 mutant cells show increased sensitivity to aure-
obasidin A, an inhibitor of the inositolphosphoryl cera-
mide synthase, while cells lacking Tdh3 showed
improved tolerance. The results are in agreement with a
link between glycolysis and sphingolipid (SLs) metabo-
lism. Engineering Tdh activity could be thus exploited
to alter the SLs status with consequences in different
aspects of yeast biotechnology.
Introduction
Energy-generating metabolic pathways have a great influ-
ence on cell physiology, and consequently understanding
the mechanisms of their regulation is of major interest.
Metabolic activities of yeast cells rely primarily on the gly-
colytic pathway, which ensures ATP for energy and a high
yield of product formation in biotechnological applications.
Increased glucose metabolism through aerobic glycolysis
is also one of the distinguishing features between normal
cells and highly proliferating cells like cancer, stem and
immune mammalian cells (Lunt and Vander Heiden, 2011).
Targeting glycolysis regulation offers thus new opportuni-
ties to improve industrial and therapeutic outcomes.
The enzymes in glycolysis have a highly heterogeneous
nature. Glycolytic isoenzymes are transcribed from differ-
ent loci or are the result of different splice-forms. In addi-
tion, they display a wide variety of expression rates and
post-translational modifications according to proliferation
phase and environment (Warmoes and Locasale, 2014).
These characteristics contribute to endow the pathway of
the required flexibility to adjust the energy generation to
the nutrient availability and the bioenergetics and biosyn-
thetic demands. In Saccharomyces cerevisiae, Tdh3 is
the main glyceraldehyde-3-phosphate dehydrogenase
(GAPDH), although two other polypeptides encoded by
Received 12 September, 2019; revised 14 October, 2019; accepted
2 November, 2019.
*For correspondence. E-mail prieto@iata.csic.es; Tel. +34 963900022;
Fax +34 963636301.
Microbial Biotechnology (2020) 13(2), 562–571
doi:10.1111/1751-7915.13513
Funding Information
This research has been supported by the Comision Interministerial
de Ciencia y Tecnologıa Project (BIO2015-71059-R) from the Span-
ish Ministry of Science, Innovation and Universities (MICINN/
FEDER).
ª 2019 The Authors. Microbial Biotechnology published by John Wiley & Sons Ltd and Society for Applied Microbiology.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and
reproduction in any medium, provided the original work is properly cited.
bs_bs_banner
TDH1 and TDH2 have been reported to exhibit GAPDH
activity (McAlister and Holland, 1985). Like their mam-
malian counterparts, Tdh3 has been traditionally consid-
ered a housekeeping protein involved in energy
generation. However, evidence indicates that GAPDH
from different origins performs glycolysis-unrelated func-
tions (Zhang et al., 2015; Muronetz et al., 2017). Yeast
Tdh3 has been described as a moonlighting protein (Gan-
cedo et al., 2016), as it facilitates the transcriptional silenc-
ing at the telomeres independently of its metabolic activity
(Ringel et al., 2013). This suggests that Tdh3 must be
tightly regulated and that this regulation may be on the
basis of its role in unrelated biological processes. For
example, downregulation of Tdh3 activity has proven
important to counteracting oxidative stress by rerouting
the carbohydrate flux from glycolysis to the pentose phos-
phate pathway (Ralser et al., 2007) and several post-
translational modifications have been mapped in the yeast
enzyme (Halim et al., 2015). Nevertheless, the impact of
these modifications, the existence of additional Tdh3’s
regulatory mechanisms and the exact function of Tdh1
and Tdh2 remain unclear.
Mechanisms of Tdh3 regulation may be based in its
ability to interact with other proteins or imply changes in
its oligomeric state. It is well known the presence of
mammalian GAPDH in complexes and aggregates of dif-
ferent proteins (Sirover, 2011); including pathogenic pro-
teins involved in various neurodegenerative disorders
(Muronetz et al., 2017). GAPDHs exist predominantly as
a tetramer, although dimeric and monomeric forms have
also been isolated (Sirover, 1999). GAPDH self-aggrega-
tion induced by different conditions, i.e. oxidative stress,
and regulated by post-translational modifications, has
been extensively reported (Nakajima et al., 2009). In
addition, Tdh3 could also interact with Tdh1 and/or Tdh2
to form hybrid tetramers, as it has been previously sug-
gested (McAlister and Holland, 1985). This regulation
may contribute to adjust the GAPDH activity and modu-
late the energy generation and the production of protec-
tive molecules according to the growth phase or under
stress conditions. However, no direct evidence of the
existence of these interactions has been provided and
their significance has been not clarified.
Here, we show for the first time evidence of the physi-
cal interaction between Tdh isoenzymes, its importance
in the stability of Tdh3 and the influence of Tdh1,2 on
the glycolytic activity and the yeast lipid metabolism.
Results and discussion
Tdh3 forms heteromeric complexes with Tdh1,2 that
localize preferentially in the soluble cytosolic fraction
Co-immunopurification experiments were conducted to
analyse the presence of mixed complexes between
Tdh1-3 isoenzymes. The extensive sequence homology
showed by the three forms of GAPDH activity in yeast
does not allow the specific detection of any of them with
polyclonal anti-GAPDH antibodies. Therefore, we carry
out a chromosomal tagging of Tdh3 at its C-terminus with
the GFP label. The addition of this tag increases the
molecular weight of Tdh3 by 28.7 kDa, which allows its
electrophoretic separation from Tdh1 and Tdh2, making
possible its specific detection (simultaneously with
Tdh1,2) using anti-GAPH antibodies. In addition, the
presence of the GFP tag allows the in vivo cellular local-
ization of Tdh3-GFP, as well as its efficient immunopre-
cipitation using anti-GFP antibodies. Protein extracts from
wild-type, tdh1, tdh2 and tdh1 tdh2 strains containing a
chromosomal copy of GFP-tagged TDH3 were resolved
by SDS–PAGE and visualized by Western blot using an
anti-GAPDH antibody. As shown in Fig. 1A (upper panel),
two major bands corresponding with Tdh3-GFP (apparent
Mw ~ 65 kDa) and Tdh1,2 (apparent Mw ~ 36 kDa) were
observed in all the strains analysed, except for the tdh1
tdh2 double mutant, where the higher-mobility band was
absent. Accordingly, the Tdh3-GFP protein in the lysates
was captured with anti-GFP antibody and the resultant
immune complexes analysed again by Western blot. As
shown in Fig. 1A (lower panel; IP), the presence of a
Tdh1,2-band was again evident in protein samples from
wild-type, tdh1 and tdh2 cells. Moreover, we observed a
weaker signal in the tdh2 mutant samples, a result that is
consistent with the low expression of TDH1 in cells grow-
ing at the exponential phase, as previously reported
(McAlister and Holland, 1985). Hence, we concluded that
Tdh1,2 physically interacts with Tdh3.
Next, we analysed whether the interaction between
Tdh isoenzymes could influence their subcellular local-
ization. Protein extracts were fractionated by centrifuga-
tion, and cytosolic (S1) and membrane-enriched (S2)
fractions were analysed by SDS–PAGE before and after
immunopurification with anti-GFP antibody (Fig. 1B). As
expected from a glycolytic enzyme, both Tdh3-GFP and
Tdh1,2 were found to be abundant in the soluble S1
fraction of wild-type cells, although a significant portion
of Tdh3-GFP was also recovered in the particulate S2
sediment (Fig. 1B). On the contrary, Tdh1,2 was hardy
visible in the S2 fraction. Consistent with this, hybrid
complexes of Tdh3 and Tdh1,2 were only recovered
from the S1-immunoprecipitates (Fig. 1B; wt, IP panel).
To check whether the distribution of Tdh3 between the
S1 and S2 fraction was dependent on the presence of
Tdh1,2, we performed the same experiment in the tdh1
tdh2 double mutant strain. As shown in Fig. 1B, absence
of Tdh1,2 did not modify the distribution of Tdh3-GFP.
Altogether, these data suggest that Tdh3, regardless of
the presence of Tdh1,2, may form homooligomers that
interact with the cellular membranes.
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Absence of Tdh1,2 stimulates Tdh3-GFP aggregation in
a growth-phase specific manner
We studied the cellular location of GFP-tagged Tdh3 in
wild-type, tdh1, tdh2 and tdh1 tdh2 cells grown in the
exponential phase (OD600 ~ 0.5) or at the diauxic shift
(OD600 ~ 15.0). The fluorescence signal of Tdh3-GFP
was localized both in the cytoplasm and nucleus of the
wild type (Fig. 2A). The simultaneous location of nuclei
with DAPI or another dye was not possible due to the
strong emission by Tdh3-GFP and its interference in other
microscope channels. However, in those cases where the
formation of aggregates is low (Fig. 2A, in the wild-type
and tdh1 mutant) it can be observed that the location of
such aggregates does not coincide with the GFP signal
that by position, morphology and size correspond to the
fraction of Tdh3-GFP located in the yeast nucleus. No
apparent differences were observed in the Tdh3 distribu-
tion in relation to the growth phase (Fig. 2A). However,
when Tdh1 was absent, the signal of Tdh3-GFP in the
diauxic-shift cultures accumulated in fluorescence foci
(Fig. 2A). In contrast, single tdh2 mutant cells displayed
focal fluorescence accumulation during their exponential
growth, a pattern that gradually dissipated as cells began
to enter the diauxic shift (Fig. 2A). These observations
suggest that Tdh1 and Tdh2 play a role as molecular part-
ners to stabilize Tdh3 and to avoid Tdh3-aggregate forma-
tion along the growth curve. As earlier mentioned, TDH2
and TDH1 are expressed mainly in the exponential phase
and when glucose becomes limiting respectively (McAlis-
ter and Holland, 1985). Consistent with this, the cells of
the double tdh1 tdh2 mutant strain exhibited Tdh3-GFP
fluorescence accumulation independently of the growth
phase (Fig. 2A). The results support the idea that Tdh1,2
could play a role in preventing the aggregation of Tdh3
and/or its interaction with other proteins to form large com-
plexes that would appear as fluorescent foci. Taking into
account the results of the Tdh3 fractionation between the
soluble and particulate fractions shown in Fig. 1B, we can
conclude that the presence of a portion of Tdh3 in the par-
ticulate fraction is independent of the formation of these
aggregates, since a part of Tdh3 was recovered into the
particulate fraction in a wild-type strain, where no aggre-
gates are detected by fluorescence microscopy and, in
addition, the amount of Tdh3 in the particulate fraction did
not increase in the tdh1 tdh2 double mutant strain
(Fig. 1B) where large aggregates are detected (Fig. 2A).
Effects on yeast viability
We wonder whether the interaction between Tdh1,2 and
Tdh3 may represent a mechanism to regulate the Tdh3
function and as a result the yeast glycolysis. There is evi-
dence that glycolytic isoenzymes provide complexity and
heterogeneity to glycolysis in eukaryotic cells living either
as interacting cell populations or as multicellular organisms
(Warmoes and Locasale, 2014). To examine this possibility
we first check whether the knockout of TDH1,2 has any
effect on yeast viability. Previous studies link the GAPDH
activity with that of the Sir2 protein (Matecic et al., 2002;
Ralser et al., 2009), a member of the sirtuins family (Sch-
wer and Verdin, 2008), implied in replicative ageing and
senescence in S. cerevisiae (Ha and Huh, 2011). It has
been hypothesized that under high glycolytic rates, the
action of GAPDH would reduce the cellular content of
NAD+, depressing the Sir2-mediated catalysis and
decreasing lifespan (Ralser et al., 2009). On the contrary,
under low glycolytic activity the opposite would be



























Fig. 1. Tdh1,2 form mixed complexes with Tdh3.
A. Protein crude extracts and anti-GFP-immunopurified (IP) samples from TDH3-GFP transformants of the BY4741 wild-type strain (wt) and its
corresponding tdh1, tdh2 and tdh1 tdh2 mutants were analysed by Western blot. Tdh3-GFP and Tdh1,2 were visualized with anti-GAPDH. Glu-
cose 6-phosphate dehydrogenase (G6PDH) was used as a loading control.
B. Protein fractions, S1 (soluble protein fraction) and S2 (membrane protein-enriched fraction) from crude extracts and anti-GFP-immunopurifed
(IP) samples of YPD-grown cultures (OD600 ~ 0.5) of TDH3-GFP transformants of wild-type (wt) and tdh1 tdh2 cells were analysed as in panel
(A). Glucose 6-phosphate dehydrogenase (G6PDH) and Kar2 were used as a loading control.
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expected to occur. As shown in Fig. 2B, deletion of TDH1
or TDH2 from wild-type cells containing Tdh3-GFP had no
major effect on the survival of S. cerevisiae. However, the
combined knockout of TDH1 and TDH2 caused a statisti-
cally significant (P < 0.01) reduction in viability (Fig. 2B).
tdh1 tdh2 mutant cells show features of increased
glycolysis
The above results suggested increased glycolysis in
tdh1 tdh2 mutant cells. To further examine this idea,
we first measured the in vitro GAPDH activity in pro-
tein extracts from wild-type, tdh1, tdh2 and tdh3 single
mutant strains, and tdh1 tdh2 and tdh1 tdh3 double
mutants. Cells lacking both Tdh2 and Tdh3 were not
analysed because their poor growth. As expected, the
loss of Tdh3 in the single tdh3 or double tdh1 tdh3
mutants caused a strong reduction of GAPDH activity
(Table 1). The TDH3 gene has been previously char-
acterized as the major contributor to the yeast GAPDH
activity (McAlister and Holland, 1985). However, nei-
ther the single disruption of TDH1 nor that of TDH2
caused apparent changes in the in vitro activity. Inter-
estingly, the simultaneous lack of Tdh1 and Tdh2
seemed to increase slightly the catalysis mediated by
Tdh3, but the variation was not statistically significant
(Table 1).
Then, we examined the growth of the mentioned
strains in liquid YPD medium. Glycolysis generates bio-
mass precursors and energy from sugars and is there-
fore a central element in the function of all anabolic
pathways, and consequently, there is a tight coupling of
cell growth to glycolysis (Lunt and Vander Heiden, 2011;
Rehberg et al., 2014). Cell pre-cultures that have
reached the stationary phase were diluted with fresh
medium and the growth, as measured as OD600, was
recorded during the initial logarithmic phase. As it is
shown in Fig. 3A the onset of growth was similar for all
the strains analysed. However, differences were soon
evident. As expected, mutant cells lacking the GAPDH
activity provided by Tdh3 displayed lower growth than
the wild type (Fig. 3A). No effects on growth were
observed by lacking Tdh1 or Tdh2, but the combined
lack of both isoenzymes increased slightly cell prolifera-
tion (Fig. 3A). Consistent with this, glucose consumption
(Fig. 3B) and total CO2 production (Fig. 3C) increased in
the tdh1 tdh2 double mutant as compared with the wild






























Fig. 2. Lack of Tdh1 and Tdh2 influence cell viability and Tdh3-ag-
gregate formation.
A. Wild-type (wt), tdh1, tdh2 and tdh1 tdh2 mutant strains express-
ing Tdh3 fused to GFP were harvested in the early exponential
phase or at the diauxic shift. Living cells were observed with a dif-
ferential interference contrast (DIC) and by fluorescence microscopy
(GFP). A representative experiment is shown.
B. Strains shown in (A) were analysed for cell viability. The graph shows
the percentage of surviving cells for 72 h of culturing in YPD medium.
Details are given in the Experimental procedures section. Data repre-
sent the mean value ( SD) of three independent experiments.




BY4741 5.78  0.90
tdh1 5.74  0.95
tdh2 5.86  0.89
tdh3 2.00  0.62*
tdh1 tdh2 6.16  0.68
tdh1 tdh3 1.84  0.48*
aThe in vitro GAPDH of yeast cells of the BY4741 wild type, and its
corresponding tdh mutant strains, was assayed as described in the
Experimental procedures section. Data represent the mean value (
SD) of three independent experiments. Mutant samples denoted
with * were significantly different from those of the wild type
(P < 0.01).
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Phenotypic characterization reveals an alteration of the
sphingolipid metabolism induced by the Tdh-isoenzymes
profile
Glycolysis is inefficient in terms of ATP production, as it
compares with the oxidative phosphorylation (Berg et al.,
2007). Therefore, glycolytic metabolism in proliferating
cells is mainly utilized to provide substrates of anabolic
pathways, among them the sphingolipid (SLs) biosynthe-
sis (Vander Heiden et al., 2009), as it has been estab-
lished in models of highly glycolytic cells (Stathem et al.,
2015). Indeed, different glycolytic intermediates, such as
glucose 6-phosphate, dihydroxyacetone phosphate and
3-phosphoglycerate are precursors of inositol, phospha-
tidic acid and serine, which in turn, are substrates for the
biosynthesis of long chain bases (LCBs), ceramides
(Cer) and complex SLs classes in S. cerevisiae (Henry
et al., 2012; Megyeri et al., 2016; Olson et al., 2016; see
Fig. 4). In this line, recent studies demonstrate that SLs
and serine synthesis are tightly linked (Hwang et al.,
2017) and that serine availability influences cell prolifera-
tion (Gao et al., 2018). Finally, several drugs that affect
SLs metabolism can be easily used to estimate the
impact of gene mutations in this anabolic branch.
According to all of this, we investigated whether the loss
of either Tdh1,2 or Tdh3 in wild-type cells had an effect
on SLs production.
We first analysed the tolerance to aureobasidin A
(AbA), a highly specific inhibitor of Aur1, the yeast inosi-
tolphosphoryl ceramide (IPC) synthase (Nagiec et al.,
1997; see Fig. 4). Exposure to AbA kills growing yeast
cells (Endo et al., 1997; Nagiec et al., 1997), an effect that
has been mainly related to the accumulation of toxic Cer.
Increased Cer levels disturb membrane permeability,
induce lethal mitophagy and trigger cell apoptosis (Sen-
telle et al., 2012), and thus, cells deficient in SLs synthesis
are resistant to AbA (Schorling et al., 2001). On the con-
trary, increased Cer accumulation, i.e. by upregulation of
LCBs biosynthesis, impaired ceramidase function and
others, exacerbates the sensitivity of yeast cells to the
drug (Vallee and Riezman, 2005). As shown in Fig. 5A,
tdh1 and tdh2 single mutants grew on YPD or SCD plates
containing AbA as did the wild-type strain. Remarkably,
cells of the tdh3 and tdh1 tdh3 mutants showed increased
tolerance to the toxicity of AbA, while those of the tdh1
tdh2 double mutant strain displayed a severe sensitivity in
either YPD or SCD medium (Fig. 5A).
Then, we assessed the growth of the yeast strains
under study in the presence of myriocin (Myr), an inhibi-





























































Fig. 3. Initial logarithmic phase.
A. Cells of the BY4741 wild type (wt) and its corresponding tdh1, tdh2, tdh3, tdh1 tdh2 and tdh1 tdh3 mutant strains were pre-grown in liquid
YPD medium, refreshed in the same medium (initial OD600 ~ 0.05), and their growth was followed for 10 h. Data represent the mean value (
SD) of two biological replicates.
B. The mentioned strains, wild-type (wt), tdh3 and tdh1 tdh2 were further analysed for glucose consumption. YPD culture medium was inocu-
lated with yeast biomass and the residual glucose determined along the experiment as indicated in the Experimental procedures section.
Values are the mean ( SD) of three independent experiments.
C. YPD-inoculated cultures of the indicated strains were assayed for gas production. The total gas accumulated (ml) during the time-course of
the experiment is shown. Data represent the mean value ( SD) of three independent experiments.
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et al., 2013), the enzyme complex that catalyses the first
step in the SLs biosynthesis pathway (Megyeri et al.,
2016; Olson et al., 2016). Unlike AbA, exposure to Myr
reduces the levels of LCBs and Cer (see Fig. 4), and
thus, cells sensitive to AbA are expected to be more tol-
erant to Myr and vice versa. As it is shown in Fig. 5B,
cells harbouring a TDH3 deletion were more sensitive to
Myr than the wild-type strain, although the phenotype
was very subtle. We also observed than cells of the dou-
ble tdh1 tdh2 mutant grew better than those of the wild-
type or the single tdh1 or tdh2 mutants (Fig. 5B). Hence,
the data suggest that the synthesis of SLs is stimulated
in the tdh1 tdh2 strain, while the loss of the main
GAPDH isoenzyme Tdh3 depresses the SLs production.
Concluding remarks
The combined evidences discussed herein indeed sug-
gest that Tdh1 and Tdh2 participate in a concerted
mechanism that functions to regulate the Tdh3-mediated
GAPDH activity. This mechanism could include changes
in Tdh3’s cellular distribution according to carbon avail-
ability. Nevertheless, we were only able to show pheno-
typic changes when both isoenzymes Tdh1 and Tdh2
were absent, indicating some kind of functional overlap-
ping. Interestingly, increasing evidence supports the
notion that human GAPDH interacts with neurodegener-
ative disease-related proteins, like a-synuclein, by pro-
moting the accumulation of oligomers and toxic
aggregates (Avila et al., 2014; Mikhaylova et al., 2016).
The usefulness of S. cerevisiae as a model for the
expression of human a-synuclein showed by recent stud-
ies (Menezes et al., 2015; Fruhmann et al., 2017; Ver-
bandt et al., 2017) provide an interesting system to
check whether Tdh1,2-Tdh3 binding plays a role in the
aggregation of this protein and the possibility of using
yeast for the study of the mechanisms that underlie in
the propagation of neurodegenerative diseases.
Our data indicate that Tdh1,2 contributes to maintain
ATP and macromolecular biosynthesis as needed.
Indeed, impaired growth on AbA and increased tolerance
to Myr in tdh1 tdh2 mutant cells are consistent with
enhanced supply of serine and increased SLs metabo-
lism. In addition, these features are exactly the opposites
to those exhibited by cells deprived of Tdh3, which show
a sharp reduction of in vitro GAPDH activity. Neverthe-
less, we cannot discard that some of these effects could





























Fig. 4. Schematic representation of the sphingolipid biosynthesis pathway in yeast and its main metabolic connections with glycolytic intermedi-
ates. Glucose carbon feeds the glycolytic pathway, which is mainly used to provide substrates of anabolic pathways. In this context, the sphin-
golipid synthesis is tightly linked to serine synthesis from 3-phosphoglycerate (Vander Heiden et al., 2009; Stathem et al., 2015; Hwang et al.,
2017; Gao et al., 2018). Only some glycolytic intermediates, genes involved and key metabolic steps for the discussion are represented. Addi-
tional information can be found in recent reviews (Henry et al., 2012; Megyeri et al., 2016; Olson et al., 2016). Abbreviations: AUR1, aureoba-
sidin A resistance, phosphatidylinositol:ceramide phosphoinositol transferase; 1,3-BPG, 1,3-bisphosphoglycerate; DHAP, dihydroxyacetone
phosphate; Glucose 6-P, glucose 6-phosphate; GA3P, glyceraldehyde-3-phosphate; TDH1-3, glyceraldehyde-3-phosphate dehydrogenase, iso-
zyme 1-3; IPC, inositolphosphoryl ceramide; LAC1, LAG1 cognate, ceramide synthase component; LAG1, longevity assurance gene, ceramide
synthase component; LCBs, long-chain bases; LCB1, long-chain base 1, component of SPT complex; LCB2, long-chain base 2, component of
SPT complex; LIP1, Lag1/Lac1 interacting protein, ceramide synthase component; MIPC, mannosyl-inositolphosphoryl ceramide; M(IP)2C, man-
nosyl-di-(inositolphosphoryl) ceramide; PI, phosphatidylinositol; 3-PG, 3-phosphoglycerate; PGK1, 3-phosphoglycerate kinase; PYR, pyruvate;
SPT complex, serine palmitoyltransferase complex; SUR2, sphinganine C4-hydroxylase; TSC3, temperature-sensitive suppressors of Csg2
mutants, component of SPT complex; TSC10, temperature-sensitive suppressors of Csg2 mutants, 3-ketosphinganine reductase.
ª 2019 The Authors. Microbial Biotechnology published by John Wiley & Sons Ltd and Society for Applied Microbiology., Microbial
Biotechnology, 13, 562–571
Tdh3 interacts with and is regulated by Tdh1,2 567
functions. There is experimental evidence that Tdh3 is a
moonlighting protein (Ringel et al., 2013; Gancedo et al.,
2016), although more work is required to validate this in
our experimental context. Meanwhile, our study estab-
lishes a link between glycolysis and SLs metabolism,
and identifies GAPDH isoenzymes as putative targets
for strain manipulation. Understanding how these and
other components of the carbon central pathway are reg-
ulated in response to stress conditions or in industrial
environments may facilitate the optimization of
biotechnological processes by providing strategies for
metabolic engineering.
Experimental procedures
Strains, plasmids, media and culture conditions
The S. cerevisiae strains, oligonucleotides and plasmids
used in this study are listed in the Supporting information
section (Tables S1–S3). Yeast cells were cultured at





SCD SCD + Myr
(A)
(B)
Fig. 5. The profile of Tdh isoenzymes influences yeast sphingolipid status.
A. Growth of the BY4741 strains, wild-type (wt), tdh1, tdh2, tdh3, tdh1 tdh2 and tdh1 tdh3 was assayed in YPD or SCD medium in the absence
or presence of 0.0675 lM aureobasidin A (AbA).
B. The sensitivity to myriocin (Myr) of the same strains was checked in SCD medium containing 1.0 lM of the drug. Representative experi-
ments are shown.
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glucose). SCD contained 2% glucose as a carbon
source and the appropriate amino acid drop-out mixture
(Formedium, England). Mutant strains lacking Tdh1 and/
or Tdh2 were constructed by PCR-based gene replace-
ment using the kanMX4, natMX4 and hphMX4 disruption
modules contained in plasmids pFA6a-kanMX4 (Wach
et al., 2004), pAG25 or pAG32 (Goldstein and McCus-
ker, 1999), respectively (Table S3), and synthetic
oligonucleotides (Table S2). Gene disruptions were con-
firmed by diagnostic PCR (Table S2). S. cerevisiae
strains were transformed as previously described
(Rodrıguez-Vargas et al., 2007).
For plate phenotype experiments, cells were grown to
the mid-exponential phase at 30C (OD600 ~ 0.5). Then,
10-fold serial dilutions were prepared and 3 ll aliquots of
three dilutions (10–103) were applied over the agar-
gelled plates. Colony growth was inspected after 2–
4 days of incubation at 30C. Stock solutions of
1 mg ml1 AbA (ethanol) and 2 mM Myr (ethanol:
DMSO; 80:20, v:v) were prepared, sampled in small vol-
umes and stored at 20C until use. For each experi-
ment, a fresh sample was thawed and diluted at the
indicated concentration.
Preparation of protein extracts and Western blot analysis
Protein extracts, protein separation by SDS–PAGE and
electroblotting were carried out as previously described
(Garcıa-Marques et al., 2016). A mouse-raised antibody,
which recognizes the GAPDH proteins (Delgado et al.,
2001) was kindly provided by D. Gozalbo. The antibody
against Kar2 (1:10,000 dilution), a generous gift of J.L.
Brodsky, and a commercial anti-G6PDH antibody
(1:3,000; cat#8866; Cell Signaling, Danvers, MA, USA)
were used as loading control of membrane and cytosolic
proteins respectively. Tdh3-GFP was also detected with
a monoclonal anti-GFP antibody (1:3,000;
cat#11814460001; Roche, Mannheim, Germany). As a
secondary antibody, a horseradish peroxidase-conju-
gated goat anti-rabbit (1:2000, cat# 7074; Cell Signaling)
or a rabbit anti-mouse (1:5,000, cat# P0260; Dako,
Carpinteria, CA, USA) was used. Blots were developed
by using a Pierce ECL kit (ThermoFisher Scientific,
Rockford, IL, USA). Images were captured with the Las-
1000 Plus imaging system (Fuji, Kyoto, Japan) and pro-
cessed identically by using Photoshop CS5.1 (Adobe
System, San Jose, CA, USA).
Protein fractionation and co-immunoprecipitation
experiments
Cells expressing a chromosomal TDH3-GFP allele were
lysed in ice-cold buffer (50 mM HEPES, pH 7.4, 50 mM
NaCl), and the corresponding protein extracts were
centrifuged at 500 x g for 5 min to remove unbroken
cells and glass beads. The clear supernatants were
recentrifuged at 17 900 g for 10 min. The supernatant
(S1, the soluble protein fraction) was collected, and the
membrane-associated proteins and protein aggregates
were extracted by incubating the pellet on ice for 30 min
with the same volume of lysis buffer that contained 1%
Triton X-100 and 0.001% Na+-deoxycholate. The protein
extract was recentrifuged and the new supernatant (S2,
the membrane protein-enriched fraction) was recovered.
Tdh3-GFP was immunoprecipitated as described previ-
ously (Garcıa-Marques et al., 2016) by using Dyn-
abeads Protein A/G (ThermoFisher Scientific)
conjugated with an anti-GFP mouse monoclonal anti-
body (3 µl), separated by SDS–PAGE and immunoblot-
ted with anti-GAPDH, as described above.
Enzyme activity determinations
Glyceraldehyde-3-phosphate dehydrogenase activity
(GAPDH) was determined spectrophotometrically
(McAlister and Holland, 1985). All the assays were per-
formed at 25C. One unit is defined as the amount of
enzyme that transforms 1 nmole of NAD+ per minute
and unit of OD600 under assay conditions. Values repre-
sent the mean ( SD) of three independent experi-
ments.
Gas production and glucose consumption measurements
The volume of gas produced by yeast cells was moni-
tored in a Fermograph II apparatus (ATTO Co., Ltd.,
Tokyo, Japan). Fifty millilitres of YPD was inoculated
with yeast biomass (initial OD600 ~ 0.025) and incubated
at 30C with low shaking (80 rpm). CO2 production was
recorded at 30 min intervals for 480 min. Values are
expressed as total CO2 (ml) accumulated during the indi-
cated time and represent the mean ( SD) of three inde-
pendent experiments.
Glucose was assayed by the 3,5-dinitrosalicylic acid
(DNS) colorimetric method (Miller, 1959). Aliquots
(250 ll) of the yeast suspension were removed over the
course of the experiment, centrifuged at 3,000 9 g for
2 min (4C), and the supernatants collected for further
analysis with the DNS reagent. Equal amounts of yeast
biomass (initial OD600 ~ 0.025) were tested in YPD med-
ium. Values are expressed as the percentage of glucose
in the culture medium (g per 100 ml) and represent the
mean ( SD) of three independent replicates.
Fluorescence microscopy
The yeast cells grown in the early exponential phase
(OD600 ~ 0.5) or diauxic phase (OD600 ~ 15) were used.
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Chromosomal GFP-tagged Tdh3 was analysed in the liv-
ing cells grown on YPD. The aliquots (1.2 ll) of the cul-
tures were placed onto microscope slides and covered
with 18 x 18 mm coverslips. Samples were analysed
under an Axioskop 2 Fluorescence Microscope (Zeiss
Inc., Jena, Germany), and pictures were taken with a
SPOT digital camera (Diagnostic Instruments Inc., Ster-
ling Heights, MI, USA) at identical exposures and pro-
cessed identically by using Photoshop CS5.1 (Adobe
System).
Viability assay
Yeast cultures were incubated overnight in SCD at 30C
with adequate shacking. Then, cells were refreshed at
OD600 ~ 0.1. This time point was considered time 0.
Then, cultures were maintained under the same condi-
tions for 24, 48 and 72 h. At each time, aliquots from the
culture were harvested, washed, resuspended in PBS
buffer and analysed for cell viability by using a flow
cytometer Muse Cell Analyser (Millipore, Darmstadt,
Germany) and the ‘Count and Viability’ kit reagent (Milli-
pore). Data are expressed as the percentage of survival
and represent the mean ( SD) of three independent
experiments.
Statistical analysis
Sample averages were compared by a Student’s t-test
with the Excel software (Microsoft). The samples
denoted with * were significantly different (P < 0.05).
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